During the past decade, City Clinical Hospital No.2 conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "City Clinical Hospital No.2" are "Severe Hypertriglyceridemia" (2 trials) and "Pulmonary Disease, Chronic Obstructive" (1 trials). Many other conditions were trialed in "City Clinical Hospital No.2" in a lesser frequency.

Most popular intervention types in "City Clinical Hospital No.2" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Fenofibrate" (2 trials), "K-877" (2 trials), "Placebo (for K-877)" (2 trials), "Placebo (for Fenofibrate)" (1 trials) and "Spiolto® Respimat®" (1 trials). Other intervention names were less common.

The vast majority of trials in "City Clinical Hospital No.2" are 3 trials for "All" genders.

Currently, there are NaN active trials in "City Clinical Hospital No.2". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in City Clinical Hospital No.2, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in City Clinical Hospital No.2, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".